Identification
Personal identification
- Full name
- CARLA MARIA MAGNO BARTOSCH
Citation names
- BARTOSCH, CARLA
Author identifiers
- Ciência ID
- 881F-BDAC-46FE
- ORCID iD
- 0000-0003-0646-7667
Telephones
- Mobile phone
-
- 964233076 (Personal)
Knowledge fields
- Natural sciences - Biological Sciences - Molecular Biology
- Medical and Health Sciences - Basic Medicine - Pathology
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
Portuguese | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | |
Portuguese | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | |
Spanish; Castilian | Intermediate (B1) | Advanced (C1) | Intermediate (B1) | Intermediate (B1) | |
Spanish; Castilian | Intermediate (B1) | Advanced (C1) | Intermediate (B1) | Intermediate (B1) | |
English | Advanced (C1) | Advanced (C1) | Advanced (C1) | Advanced (C1) | |
French | Beginner (A1) | Intermediate (B1) | Beginner (A1) | Beginner (A1) |
Education
Degree | Classification | |
---|---|---|
2021/10/01 - 2022/10/01
Concluded
|
Postgraduate Programme in Health Services Management. (Pós-Graduação)
Universidade do Porto Porto Business School, Portugal
|
17 |
2009 - 2017
Concluded
|
Programa Doutoral em Medicina e Oncologia Molecular (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
"Endometrial carcinoma: study of pathology and epigenetic features" (THESIS/DISSERTATION)
|
Aprovado com distinção |
2013/03 - 2014/11
Concluded
|
Clinical Scholars Research Training (CSRT) Certificate Program (Pós-Graduação)
Harvard Medical School, United States
|
|
1998 - 2004
Concluded
|
Medicina (Licenciatura)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"n/a" (THESIS/DISSERTATION)
|
16 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2017/10/01 - Current | Researcher (Research) | Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal |
Teaching in Higher Education
Category Host institution |
Employer | |
---|---|---|
2018/09/01 - Current | Assistant (University Teacher) | Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2019/10/01 - Current | Attending Pathologist | Centro Hospitalar Universitário de São João, Portugal |
2011/10/01 - Current | Attending Pathologist | Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal |
2009 - 2014 | Triage Physician | Centro Hospitalar do Médio Ave EPE, Portugal |
2011/07/05 - 2011/10/01 | Attending Pathologist | Centro Hospitalar Universitário de São João, Portugal |
2006/03/26 - 2011/07/05 | Pathology Resident | Centro Hospitalar Universitário de São João, Portugal |
2011/01 - 2011/04 | Visiting Fellow in Gynecopathology | Massachusetts General Hospital, United States |
2007 - 2010 | Triage Physician | Centro Hospitalar Tâmega e Sousa EPE, Portugal |
Projects
Contract
Designation | Funders | |
---|---|---|
2022/01 - Current | Molecular classification of endometrial carcinoma analysis of a comprehensive cancer centre's cohort
233/21
Researcher
|
|
2021/09 - Current | Gestational trophoblastic disease in Portugal: taking the first step towards a national referring centre
208/021
Supervisor
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
|
Ongoing
|
2019 - Current | Peritoenal and distant metastases of ovarian high grade serous carcinoma
.
Researcher
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
|
2017 - Current | Squamous cell carcinoma: diagnostic tools to discriminate between pulmonary primary tumor and metastasis from the cervix
.
Researcher
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
|
2017 - Current | Challenges in surgical-pathology approach of sentinel lymph nodes in endometrial and cervical carcinoma
.
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Ongoing
|
Other
Designation | Funders | |
---|---|---|
2020 - Current | Risk Prediction in Endocervical Adenocarcinoma: International Society of Gynecological Pathologists (ISGyP) Multi Centre Retrospective
Observational Study
.
Researcher
Queen Mary University of London, United Kingdom
|
|
2019 - Current | Implications of second allele alterations for mismatch repair protein deficiency screening
.
Principal investigator
|
|
2018 - Current | Stemness and metabolic plasticity in hereditary breast-ovarian cancer syndrome
.
Supervisor
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
|
Ongoing
|
2017 - Current | DNA methylation biomarkers as detection and triage tools in a population-based cervical cancer screening program
.
Researcher
|
Ongoing
|
2017 - Current | Pre-term labor: etiology and screening
.
Supervisor
Centro Hospitalar Universitário de São João, Portugal
|
Ongoing
|
2019 - 2023 | Gynecological tumors and tumor-like lesions in children and adolescents: experience at a cancer center
.
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
|
2009/01/01 - 2017/09/05 | Genetic and environmental interaction in the pathogenesis of endometrial cancer: relevance of epigenetic alterations.
CES494-010
Principal investigator
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
|
Concluded
|
2014 - 2016 | Phenotypic Intratumoral Heterogeneity of Endometrial Carcinomas
CES 494/10
Supervisor
|
Concluded
|
Outputs
Publications
Journal article |
|
Thesis / Dissertation |
|
Activities
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2021 - Current | Gestational trophoblastic disease in Portugal: taking the first step towards a national referring centre
Supervisor
|
Oncologia (Master)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2021 - Current | Challenges in the application of sentinel lymph node in endometrial cancer
Co-supervisor
|
Ciência de Dados de Saúde (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2018 - Current | Stemness and metabolic plasticity in hereditary breast-ovarian cancer syndrome
Co-supervisor
|
Programa Doutoral em Áreas da Biologia Básica e Aplicada (PhD)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|
2017 - Current | Pre-term labor: etiology and screening
Co-supervisor
|
Programa Doutoral em Medicina (PhD)
Universidade do Porto Faculdade de Medicina, Portugal
|
2022 - 2023 | Identifying epigenetic drug targets that associate with immune microenvironment changes in endometrial carcinomas
Supervisor
|
Universidad de Oviedo, Spain
|
2019 - 2021 | Implications of second allele alterations for mismatch repair protein deficiency screening
Supervisor
|
Biotecnologia para as Ciências da Saúde (Master)
Universidade de Trás-os-Montes e Alto Douro Escola de Ciências da Vida e do Ambiente, Portugal
|
2014 - 2016 | Intratumoral heterogeneity of endometrial carcinomas
Co-supervisor
|
Master degree programme in Medicine and Molecular Oncology (Master)
Universidade do Porto Faculdade de Medicina, Portugal
|
Association member
Society Organization name | Role | |
---|---|---|
2019 - Current | European Organization for Treatment of Trophoblastic Disease (EOTDD) | Member of the Pathology and Genetics Working Party |
2016 - Current | International Society of Gynecological Pathologists (ISGyP) | |
2014 - Current | Portuguese Association for Cancer Research (ASPIC)/European Association for Cancer Research (EACR) | |
2013 - Current | Ovarian Cancer Portuguese Study Group (GPECO) | |
2013 - Current | European Network Individualized Treatment Endometrial Cancer (ENITEC) | |
2010 - Current | European Society of Pathology (ESP) | |
2010 - Current | Portuguese Society of Anatomic Pathology |
Distinctions
Award
2023 | Best Digital Poster in Gynecology award for the work: "Four cases of mesonephric carcinoma of the uterine cervix: a rare histology". 20º National Oncology Congress |
2023 | Best Oral Communication in Gynecology award for the work: "Recurrence or new primary: comparison of the genetic profile between tumors of the vulva". 20º National Oncology Congress |
2023 | Honourable mention in Oral Communication for the work: "Implementation of endometrial carcinoma molecular classification: experience of two Portuguese Centers". 19º Congresso Nacional de Anatomia Patológica |
2022 | Best Poster award in for the work: ”P-caderina: a promising biomarker for ovarian high grade serous carcinoma”. 19º National Congress Oncology |
2022 | Best Oral Communication award for the for the work: "Recycling ovarian cancer ascites to monitor resistance to therapy". 19º National Congress Oncology |
2020 | Honourable mention for the research project: "Second allele inactivation mechanisms in tumors associated with Lynch Syndrome: a new frontier for diagnostic and therapeutic approach". 2nd edition of the MSD research prize for health. |
2014 | First Prize Award of Best Poster for the work: "Histopathological findings in hysterectomy specimens of women with lynch syndrome".
3th Gynecological Oncology Course
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
|
2014 | Award in Recognition for Excellence, Clinical Scholars Research Training II Program, Portugal - Harvard Medical Shool
Harvard Medical School, United States
|
2002 | First Prize Award for the work: "Human Endometrium Ultrastructure during the implantation window"- Silva Araújo Prize
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
|